Complete financial analysis of Health & Life Co., Ltd. (1781.TWO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Health & Life Co., Ltd., a leading company in the Healthcare industry within the Healthcare sector.
You may be interested
- Orexo AB (publ) (ORX.ST) Income Statement Analysis – Financial Results
- Arabian International Healthcare Holding Company (9530.SR) Income Statement Analysis – Financial Results
- Affiliated Managers Group, Inc. (MGRD) Income Statement Analysis – Financial Results
- Techindia Nirman Limited (TECHIN.BO) Income Statement Analysis – Financial Results
- Knight Club Capital Asset Management Public Company Limited (KCC.BK) Income Statement Analysis – Financial Results
Health & Life Co., Ltd. (1781.TWO)
About Health & Life Co., Ltd.
Health & Life Co., Ltd. manufactures and sells products for cardiovascular disease, in-vitro diagnostics, and respiratory care worldwide. It offers vibrating mesh nebulizers, blood pressure monitor products, IR thermometers, and hearing aid devices. The company was founded in 1996 and is based in New Taipei City, Taiwan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 601.17M | 797.54M | 811.88M | 774.16M | 421.16M |
| Cost of Revenue | 508.07M | 699.82M | 766.12M | 647.09M | 375.44M |
| Gross Profit | 93.11M | 97.73M | 45.76M | 127.06M | 45.73M |
| Gross Profit Ratio | 15.49% | 12.25% | 5.64% | 16.41% | 10.86% |
| Research & Development | 16.16M | 17.34M | 22.81M | 21.33M | 19.79M |
| General & Administrative | 96.80M | 101.35M | 92.55M | 97.17M | 87.07M |
| Selling & Marketing | 20.15M | 24.12M | 27.29M | 25.32M | 16.56M |
| SG&A | 116.95M | 125.47M | 119.84M | 122.49M | 104.30M |
| Other Expenses | 0.00 | 31.28M | 14.72M | 283.45M | 0.00 |
| Operating Expenses | 134.17M | 142.81M | 142.66M | 143.81M | 124.09M |
| Cost & Expenses | 642.23M | 842.62M | 908.77M | 790.90M | 499.53M |
| Interest Income | 2.26M | 775.00K | 1.95M | 980.00K | 787.00K |
| Interest Expense | 5.27M | 3.14M | 3.08M | 3.13M | 4.05M |
| Depreciation & Amortization | 24.44M | 24.18M | 17.17M | 11.87M | 15.28M |
| EBITDA | -7.95M | 11.85M | -65.47M | 278.30M | -56.74M |
| EBITDA Ratio | -1.32% | 1.40% | -7.77% | 36.11% | -14.98% |
| Operating Income | -41.06M | -13.02M | -80.22M | 267.68M | -78.36M |
| Operating Income Ratio | -6.83% | -1.63% | -9.88% | 34.58% | -18.61% |
| Total Other Income/Expenses | 3.50M | -2.44M | 13.59M | 281.29M | 3.39M |
| Income Before Tax | -37.56M | -15.47M | -83.30M | 264.52M | -74.97M |
| Income Before Tax Ratio | -6.25% | -1.94% | -10.26% | 34.17% | -17.80% |
| Income Tax Expense | -4.33M | 2.08M | -20.96M | 58.54M | 1.47M |
| Net Income | -33.23M | -17.55M | -62.34M | 205.98M | -76.44M |
| Net Income Ratio | -5.53% | -2.20% | -7.68% | 26.61% | -18.15% |
| EPS | -0.70 | -0.37 | -1.31 | 4.34 | -1.61 |
| EPS Diluted | -0.70 | -0.37 | -1.31 | 4.34 | -1.61 |
| Weighted Avg Shares Out | 47.41M | 47.41M | 47.41M | 47.41M | 47.41M |
| Weighted Avg Shares Out (Dil) | 47.41M | 47.41M | 47.41M | 47.51M | 47.41M |
No news found for: 1781.TWO
Source: https://incomestatements.info
Category: Stock Reports